Budesonide vs Mometasone Furoate in Chronic Cough With Rhinitis or Sinusitis

Randomised, open-label trial of budesonide and mometasone furoate nasal spray in chronic cough, upper airway cough syndrome (UACS) and chronic rhinitis (2 arms), sponsored by Medical University of Silesia. Primary endpoint: Change from baseline in cough severity measured by Visual Analog Scale (VAS) at 4 weeks. Started Jul 2022; status: completed.